Holen Sie sich die Stockscreener-App
2.80
2.19%
0.06
Handel nachbörslich:
2.86
0.06
+2.14%
Schlusskurs vom Vortag:
$2.74
Offen:
$2.74
24-Stunden-Volumen:
1.27M
Relative Volume:
0.67
Marktkapitalisierung:
$216.57M
Einnahmen:
$10.42B
Nettoeinkommen (Verlust:
$-38.77M
KGV:
-5.4902
EPS:
-0.51
Netto-Cashflow:
$323.54M
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
-48.91%
1J Leistung:
-69.96%
1-Tages-Spanne:
$2.69
$2.82
1-Wochen-Bereich:
$2.69
$2.82
52-Wochen-Spanne:
$2.38
$10.43
Accendra Health Inc Stock (OMI) Company Profile
Firmenname
Accendra Health Inc
Sektor
Branche
Telefon
(804) 723-7000
Adresse
10900 NUCKOLS ROAD, GLEN ALLEN, VA
Compare OMI vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMI
Accendra Health Inc
|
2.80 | 216.57M | 10.42B | -38.77M | 323.54M | -0.51 |
|
MCK
Mckesson Corporation
|
995.69 | 121.38B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
371.44 | 72.49B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
226.35 | 54.09B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
80.21 | 9.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.4414 | 1.12B | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (OMI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2024-07-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-12 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-10-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Fortgesetzt | Citigroup | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-30 | Fortgesetzt | JP Morgan | Underweight |
| 2020-12-17 | Hochstufung | UBS | Neutral → Buy |
| 2020-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-05-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-01-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-10 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-01 | Bestätigt | Barclays | Underweight |
| 2018-10-31 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-03-08 | Eingeleitet | Barclays | Underweight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2017-12-19 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-01 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2016-11-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2016-04-21 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2016-03-16 | Eingeleitet | Credit Suisse | Underperform |
| 2015-12-07 | Bestätigt | RBC Capital Mkts | Sector Perform |
Alle ansehen
Accendra Health Inc Aktie (OMI) Neueste Nachrichten
Owens & Minor, Inc. (OMI) Stock Analysis: Is The 94% Potential Upside Worth The Risk? - DirectorsTalk Interviews
ACH Technical Analysis & Stock Price Forecast - Intellectia AI
Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey
Accendra Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:ACH) 2026-02-25 - Seeking Alpha
Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa
MSN Money - MSN
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Accendra Health, Inc. Provides Earnings Guidance for 2026 - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Accendra Health : 4th Quarter 2025 Earnings Supplemental Slides - marketscreener.com
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) EV-to-OCF : -23.35 (As of Jan. 07, 2026) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Diluted net income available to common stockholders of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Net current asset value per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Finanzdaten der Accendra Health Inc-Aktie (OMI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.13%
2.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):